LUCD Earnings — Lucid Diagnostics Inc. Common Stock Post-ER Performance | BigEarnings
LUCD — Lucid Diagnostics Inc. Common Stock
XNAS · Healthcare · Medical Devices
Price$1.03
Market Cap$196.5M
P/E—
52W Range$0.90 – $1.63
Next Earnings2026-08-12
About Lucid Diagnostics Inc. Common Stock
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
